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Abstract
The vaginal microbiota, normally characterized by lactobacilli presence, is crucial for vaginal health. Members belonging to 
L. crispatus and L. gasseri species exert crucial protective functions against pathogens, although a total comprehension of 
factors that influence their dominance in healthy women is still lacking. Here we investigated the complete genome sequence 
and comprehensive phenotypic profile of L. crispatus strain BC5 and L. gasseri strain BC12, two vaginal strains featured by anti- 
bacterial and anti- viral activities. Phenotype microarray (PM) results revealed an improved capacity of BC5 to utilize different 
carbon sources as compared to BC12, although some specific carbon sources that can be associated to the human diet were 
only metabolized by BC12, i.e. uridine, amygdalin, tagatose. Additionally, the two strains were mostly distinct in the capacity to 
utilize the nitrogen sources under analysis. On the other hand, BC12 showed tolerance/resistance towards twice the number of 
stressors (i.e. antibiotics, toxic metals etc.) with respect to BC5. The divergent phenotypes observed in PM were supported by 
the identification in either BC5 or BC12 of specific genetic determinants that were found to be part of the core genome of each 
species. The PM results in combination with comparative genome data provide insights into the possible environmental factors 
and genetic traits supporting the predominance of either L. crispatus BC5 or L. gasseri BC12 in the vaginal niche, giving also 
indications for metabolic predictions at the species level.
DATA SummARy
The genome sequences of Lactobacillus crispatus BC5 and 
L. gasseri BC12 have been deposited under NCBI BioProject 
Accession PRJNA596958 and PRJNA596963, respectively. 
The authors confirm all supporting data have been provided 
within the article or through supplementary data files.
InTRoDuCTIon
The human vaginal microbial community is composed of 
several microorganisms, which establish complex interac-
tions with the host. In healthy reproductive- aged women, 
the vaginal environment is generally dominated by Lacto-
bacillus genus, and most women display the prevalence 
of one species among L. crispatus, L. gasseri, L. iners and 
L. jensenii [1]. Lactobacilli stimulate the preservation of 
vaginal homeostasis and protect the host mucosa from 
colonization and growth of different pathogens [2–4]. These 
protective functions have been associated with different 
action mechanisms, i.e. immunomodulation, production 
of antimicrobials, competitive exclusion, pH lowering and 
production of external vesicles [5–7]. Consequently, the 
decrease of lactobacilli abundance is usually coupled with 
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pathologies and the shift from an eubiosis to a dysbiosis 
condition [8]. Among vaginal Lactobacillus spp. strains 
with health promoting activities, L. crispatus BC5 and 
L. gasseri BC12 have been extensively assessed for their anti-
fungal, antibacterial and antiviral activities [2–4, 7, 9]. In 
addition, BC5 and BC12 strains were characterized in terms 
of metabolomic profiles during growth in MRS medium 
and for their interaction with epithelial cells [10, 11].
The microbial community composition in the vaginal niche 
is highly dynamic and influenced by several factors, such as 
hormones levels, pregnancy, urogenital infections and drug 
treatments [12]. A better understanding of factors that lead 
to the colonization and stability of Lactobacillus species in 
the cervicovaginal tract is urgent to develop novel strategies 
for woman health maintenance. In particular, despite the fact 
that several studies have analysed and compared lactobacilli 
genomics [1, 13, 14], a full comprehension of the efficiency 
in nutrients' utilization and resistance to stressors is lacking. 
In this context, phenotype microarrays (PM) provide insights 
into the metabolic profiling of microbial cells by assessing the 
utilization of nutrients and sensitivity to toxic compounds and 
chemical stressors [15]. Despite its limitations associated to 
in vitro approaches (i.e. exclusion of the effect of the host and 
other bacteria), PM is a high- throughput and standardized 
technology that can be combined with genome- wide analysis 
to unravel phenotypic and genotypic insights into ecological 
and functional aspects of clinical and environmental bacterial 
species [16–19].
In the present study, we performed PM and whole- genome 
sequencing of the two vaginal strains L. crispatus BC5 and 
L. gasseri BC12. The draft genomes of L. crispatus BC5 
and L. gasseri BC12 were analysed to detect the genetic/
genomic traits related to the PM features concerning these 
two strains’ ability to utilize various carbon and nitrogen 
sources and to resist/tolerate hundreds of different chemical 
stressors. The analysis of these genetic features was also 
extended by performing a comparative analysis of all the 
genomes available in the database belonging to L. crispatus 
and L. gasseri species. The results of this study provide 
insights into the genotypic and phenotypic traits supporting 
L. crispatus BC5 and L. gasseri BC12 growth in the vaginal 
niche, also giving indications on the nutritional and stress 
factors that might influence their beneficial activity. Some 
metabolic considerations at the species level are formulated 
based on the conservation of phenotype- associated genetic 
traits in each core genome.
mETHoDS
Bacterial strains and culture conditions
L. crispatus BC5 and L. gasseri BC12, previously isolated from 
human vaginal swabs [2], were routinely cultured in de Man, 
Rogosa and Sharpe (MRS) broth under static conditions or on 
MRS agar plates supplemented with 0.05 % (w/v) l- cysteine, 
at 37 °C in anaerobic jars containing Anaerocult A (Merck 
Millipore). Strains were stored at −80 °C in MRS medium 
containing 20 % (v/v) glycerol.
Whole-genome sequencing and annotation
Genomic DNA isolation was performed from 2 ml over-
night cultures of L. crispatus BC5 or L. gasseri BC12 using 
DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) 
following the protocol ‘Pretreatment for Gram- positive 
bacteria’. DNA quantification, integrity and purity were 
checked by Nanodrop spectrometer 1000- ND and on 
agarose gel. The genome sequencing was achieved using 
Illumina MiSeq technology, kit V3, 2×300 PE run, and 
sequencing reads were assembled using SPAdes [20]. 
L. crispatus BC5 genome was assembled into 50 contigs 
with an N50 of 104 423 and genome coverage of 227×, 
whereas L. gasseri BC12 genome was assembled in 48 
contigs with N50 of 106 908 and overall coverage of 358×. 
Protein- coding genes and non- coding RNA (rRNA, tRNA 
and ncRNA) were identified using the NCBI Prokaryotic 
Genome Annotation Pipeline (PGAP), Protein sequences 
were mapped to the KEGG orthology database. using 
KOfamKOALA combined with eggNOG [21, 22]. Anti-
biotic resistance genes and genetic variants associated to 
antibiotic resistance phenotypes were identified using the 
Comprehensive Antibiotic Resistance Database (CARD) in 
Impact Statement
Here we investigated the nutritional and stress- related 
genetic factors promoting the metabolic activity of 
L. crispatus BC5 or L. gasseri BC12 strains, which might 
influence their capacity to colonize and persist in the 
human vaginal niche successfully. Previous studies 
have reported the selective predominance of specific 
vaginal Lactobacillus species (including L. crispatus or 
L. gasseri). This seemed to be associated with diverse 
environmental and host factors; however, a total compre-
hension of factors that influence their dominance in 
human vaginal niche is still lacking. Our study applies 
comparative genome analyses and phenotype micro-
array assay to define the genetic/genomic traits related 
to the capabilities of L. crispatus BC5 and L. gasseri BC12 
to utilize various carbon and nitrogen sources and to 
resist/tolerate hundreds of different chemical stressors. 
Starting from the results about these two model strains, 
pan- and core- genome analyses were performed to 
detect the phenotype- associated genetic traits that char-
acterize each species, i.e. L. crispatus and L. gasseri. The 
findings presented here indicate that specific metabolic 
features and genetic traits distinguish L. crispatus from 
L. gasseri. Specific carbon and nitrogen sources as well 
as the presence of antibiotics, metals and other toxicants 
differently influence the metabolic activity of BC5 and 
BC12 strains, suggesting that distinct nutritional features 
and stress resistance capacities might play a role in the 
selective dominance of each Lactobacillus species in the 
human vaginal niche.
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strict mode [23]. Additionally, identification of antibiotic 
resistance gene families was further investigated using 
the stand- alone version of InterProScan v5.45–80.0 [24]. 
Manual curation was performed ad hoc based on literature 
information.
Phylogenomics and comparative genome analysis
Phylogenetic relatedness of BC5 and BC12 strains to 
L. crispatus and L. gasseri species was determined via average 
nucleotide identity (ANI) using the python module pyANI 
(https:// github. com/ widdowquinn/ pyani) implemented in 
Anvi’o [25].
Comparative genome analysis was performed using all 
L. gasseri and L. crispatus strains available in the NCBI 
Assembly RefSeq database in May 2020. A pan- genome 
database was built using the Anvi’o pipeline [25] with an 
inflation parameter (--mcl- inflation) of 10 to identify protein 
clusters based on sequence similarity. In this respect, a soft- 
core genome was defined considering clusters present in at 
least 90 % of genomes. Functional annotation of the proteins 
included in each cluster was finally performed using eggNOG 
[21]. Identification of gene clusters associated with vaginal 
L. crispatus and L. gasseri strains was performed using the 
Anvi’o script ‘anvi- get- enriched- functions- per- pan- group'. 
A gene cluster was considered significantly associated with 
the vaginal source when the calculated adjusted P- value was 
<0.001 and when present in at least 50 % of the vaginal strains.
Phenotype microarray and data analysis
Phenotype microarray (PM) assay was performed on 
L. crispatus BC5 and L. gasseri BC12 using PM Technology 
(Biolog, Hayward, CA, USA) in anaerobic conditions. PM 
technology is based on reducing tetrazolium violet by cells 
with active metabolism and consequent formation of purple 
colour that was automatically recorded by a camera every 
15 min [15]. Both strains were tested on Biolog microplates 
for their specific metabolic activity in the presence of 190 
different carbon sources (PM1 and PM2A), 94 nitrogen 
sources (PM3B) and their chemical sensitivity to 250 different 
drugs and chemical compounds (PM9 to 20) including heavy 
metals, antibiotics, osmolytes, antiseptics, pH stress and other 
inhibitors.
L. crispatus and L. gasseri strains were grown on MRS plates 
and then inoculated in PM plates described as follows: cells 
were removed from MRS agar plates using a cotton swab 
and inoculated in a solution composed of Inoculation Fluid 
(Biolog), DyeG (Biolog) and additive solution [the complete 
composition of the additive solutions and mixes are provided 
in Table S6 (available in the online version of this article)], at a 
cell density of T (transmittance)=65 %. All plates were inocu-
lated with 100 µl of cell suspension per well, and the anaerobic 
atmosphere was created with an Anaerocult P sachet (Sigma- 
Aldrich) placed together with each plate in a incubation bag 
sealed with tape [18]. Lastly, plates were incubated for 72 h at 
37 °C in an Omnilog automated incubator/reader (Biolog).
Metabolic data were analysed with Omnilog software (O_
PM_FM/Kin 1.20.02 and OL_PM_Par 1.20.02) and OPM 
package on R studio [26]. For PM1- 2A (carbon sources), 
PM3B (nitrogen sources), PM9-10 (Osmolytes and pH), 
PM data were referred to the value of the area under the 
curve (AUC) obtained per each compound during Omnilog 
data analysis (Table S5). In PM11C- 20B (drug and chemical 
sensitivities), each compound was present in four different 
wells at increasing concentration. Consequently, for each 
compound, we assigned a value that ranges from 0 to 4, in 
which 0 corresponds to no detection of metabolic activity 
and 4 means metabolic activity detection at the highest 
concentration tested (Table S5).
nucleotide sequence accession number
The whole genome shotgun projects of L. crispatus BC5 
and L. gasseri BC12 have been deposited at DDBJ/ENA/
GenBank under the accessions WUBT00000000.1 and 
WUBU00000000.1, respectively.
RESuLTS
Phylogenomic analyses and genome annotation of 
L. crispatus BC5 and L. gasseri BC12
Draft genomes of 2 064 185 bp with a G+C content of 36.7 
mol% for L. crispatus BC5 and 2 020 322 bp with a G+C 
content of 34.7 mol% for L. gasseri BC12 were obtained. 
These data were in line with the mean values calculated 
on 116 genomes of L. crispatus strains, and 40 genomes of 
L. gasseri strains retrieved from NCBI Assembly Database, 
i.e. size of 2.1 ± 0.18 Mbp for L. crispatus and 1.9 ± 0.26 Mbp 
for L. gasseri; % GC was 36.8±0.002 % and 34.9±0.002 %, 
respectively.
Phylogenetic relatedness of BC5 and BC12 to L. crispatus 
and L. gasseri species, respectively, was confirmed, being 
the ANI value >96.5 % for both strains (97.6 % for BC5 
vs L. crispatus ATCC33820, 97.2 % BC12 vs L. gasseri 
ATCC33323). On the other hand, in accordance with their 
belonging to a different species, the two strains shared an 
ANI of 75 %.
Genome annotation analysis identified a total of 2015 coding 
sequences (CDS) and 81 RNA genes (16 rRNAs, 62 tRNAs 
and 3 ncRNAs) in BC5 and 1934 CDS and 76 RNA genes (10 
rRNAs, 63 tRNAs and 3 ncRNA) in BC12. According to the 
NCBI Prokaryotic Annotation pipeline, 76 proteins in BC5 
and BC12 were annotated with domain of unknown func-
tion (DUF) whereas 253 and 210 proteins were identified as 
hypothetical proteins (RefSeq assembly accession for BC5 
and BC12: GCF_014654865.1 and GCF_014654855.1, respec-
tively). According to KOfam and eggNOG, 1022 proteins for 
BC12 and 955 proteins for BC5 were assigned to the KEGG 
orthology database, i.e. KEGG Orthologs (KO) (Tables S1 and 
S2). Among those belonging to the major metabolic pathways, 
by directly comparing the two strains, BC5 and BC12 shared 
174 functional orthologues (Table 1). On the other hand, 
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Table 1. Number of shared and unique functional orthologues (indicated as KO) involved in the major metabolic pathways of L. crispatus BC5 and L. 
gasseri BC12*
KEGG metabolism KEGG pathway name Shared KO LC BC5 unique KO LG BC12 unique KO
Carbohydrate metabolism Glycolysis/gluconeogenesis 13 2 3
Citrate cycle 3 – –
Pentose phosphate pathway 10 – 1
Pentose and glucuronate interconversions 1 – –
Fructose and mannose metabolism 9 – 1
Galactose metabolism 7 3 13
Starch and sucrose metabolism 13 – 1
Amino sugar and nucleotide sugar 
metabolism
21 1 3
Pyruvate metabolism 11 3 1
Glyoxylate and dicarboxylate metabolism 4 1 2
Propanoate metabolism 4 1 –
Butanoate metabolism 2 2 1
C5- branched dibasic acid metabolism – 1 1
Inositol phosphate metabolism 2 – –
Amino acids' metabolism Alanine, aspartate and glutamate 
metabolism
12 – –
Glycine, serine and threonine metabolism 7 2 –
Cysteine and methionine metabolism 9 5 –
Valine, leucine and isoleucine degradation 1 1 –
Lysine biosynthesis 4 7 –
Lysine degradation 1 – –
Arginine biosynthesis 2 1 –
Arginine and proline metabolism 1 1 –
Histidine metabolism 1 – –
Phenylalanine metabolism 1 – –
Tryptophan metabolism 2 – –
Taurine and hypotaurine metabolism 2 – –
Selenocompound metabolism 4 1 1
Cyanoamino acid metabolism 3 1 –
d- glutamine and d- glutamate metabolism 4 – –
d- alanine metabolism 4 – –
Glutathione metabolism 2 –
Continued
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KEGG metabolism KEGG pathway name Shared KO LC BC5 unique KO LG BC12 unique KO
Lipid metabolism Fatty acid degradation 1 1 –
Synthesis and degradation of ketone bodies 1 1 –
Primary bile acid biosynthesis – 1 –
Glycerolipid metabolism 7 – 1
Glycerophospholipid metabolism 8 – 1
Sphingolipid metabolism 1 – –
Nucleotide metabolism Purine metabolism 24 – 2
Pyrimidine metabolism 24 – 1
Metabolism of cofactors and vitamins Thiamine metabolism 5 – 1
Riboflavin metabolism 4 5 –
Vitamin B6 metabolism 1 1 –
Nicotinate and nicotinamide metabolism 5 1 –
Pantothenate and CoA biosynthesis 4 1 1
Folate biosynthesis 3 1 –
One carbon pool by folate 6 – –
Porphyrin and chlorophyll metabolism 2 – –
Ubiquinone and other terpenoid- quinone 
biosynthesis
1 1 2
Membrane transport ABC transporters 37 8 11
Phosphotransferase system (PTS) 17 4 13
Bacterial secretion system 9 – –
Replication and repair DNA replication 13 – –
Base excision repair 10 – –
Nucleotide excision repair 7 – –
Mismatch repair 15 1 –
Homologous recombination 18 – –
Transcription and translation RNA polymerase 5 – –
Ribosome 53 – –
Aminoacyl- tRNA biosynthesis 26 – –
RNA transport 2 – –
Total number of shared and unique KO 174 129 99
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unique KO in each strain were 129 and 99 in BC5 and BC12, 
respectively (Table 1).
Phenotype microarray of L. crispatus BC5 and  
L. gasseri BC12 and genetic traits associated with 
their phenotypic differences
Carbon sources
L. crispatus BC5 and L. gasseri BC12 showed metabolic 
activity in the presence of 61 and 54 carbon sources of 
different categories, respectively (Fig.  1a). Among these, 
both the strains displayed a preference for carbohydrates 
(over amino acids, carboxylic acids, amines, amides, esters, 
polymers, fatty acids). However, L. crispatus BC5 could 
utilize a higher number of sugars as compared to L. gasseri 
BC12 (35 by BC5 vs 32 by BC12 over the 71 carbohydrates 
under analysis). Furthermore, BC5 showed higher metabolic 
activities on 22 shared (i.e. utilized by both the strains) carbon 
sources (Fig. 1c) and the capability to utilize 18 compounds 
exclusively (indicated with * in Fig. 1a). In some cases, it 
was possible to link the higher performance of BC5 towards 
carbohydrates to the presence in its genome of specific genetic 
determinants involved in carbohydrate uptake and metabolic 
reactions. In the case of melibiose and maltotriose, only the 
L. crispatus strain possesses genes coding for systems involved 
in their import (Table 2, Fig. 2). Concerning the higher meta-
bolic activity on maltose, a maltose 6- phosphate glucosidase 
gene is present in BC5 genome but not in BC12 one (Table 2, 
Fig. 2). In α-glycosydes such as α-methyl- d- mannoside, BC5 
possesses multiple copies of the genes encoding the multiple- 
sugar- metabolism (Msm) transport system, which are 
involved in the uptake of these sugars. The higher metabolic 
activity of BC5 on lactose and galactose can be associated 
with the different degradative pathways present in the two 
strains. BC5 possesses a beta- galactosidase gene (lacZ), which 
catalyses the conversion of lactose into d- galactose that can be 
further converted into α- d- glucose- 6P (via Leloir pathway). 
Conversely, BC12 genome bears the genes of the tagatose- 6P 
pathway, in which lactose and galactose are converted into 
glyceraldeyde- 3P that can enter glycolysis. In consideration 
of sucrose, both BC5 and BC12 genomes possess the genes 
involved in converting sucrose into α- d- glucose- 6P via 
d- fructose, but only the BC5 genome carries a levansucrase/
invertase gene, needed for the conversion of sucrose into 
d- glucose and levan. The presence of an additional gene 
encoding the triose/dihydroxyacetone kinase (DhaK/DAK) 
solely in the BC5 genome might support the higher perfor-
mance shown by this strain as compared to BC12. DhaK/
DAK catalyses the direct conversion of fructose- 1P into 
glyceraldehyde- 3P via d- glyceraldehyde that might improve 
the sugar utilization kinetics.
L. gasseri BC12 showed higher performance as compared to 
L. crispatus BC5 only on a few carbon sources. In this regard, 
the L. gasseri strain showed higher metabolic activity on 
d- trehalose and the exclusive capability to utilize nine carbo-
hydrates (indicated with $ in Fig. 1a). From a genotypic point 
of view, the presence in BC12 of a tagatose 1,6- diphosphate 
aldolase gene can support the capacity of only this strain 
to utilize d- tagatose (Table  2). Similarly, the presence of 
genes encoding the N- acetylgalactosamine PTS system EIIA 
component and the enzymes involved in tagatose- 6P pathway 
can be associated to the capability of BC12 to metabolize 
N- acetylgalactosamine efficiently. BC12’s higher metabolic 
activity on trehalose is probably due to a treC gene in BC12 
that encodes the trehalose-6- phosphate hydrolase involved in 
the conversion of trehalose- 6P into d- glucose and d- glucose-
 6P. Conversely, BC5 possesses the maltose 6- phosphate 
glucosidase gene that can recognize the trehalose- 6P as a 
substrate but with a different specificity than TreC, therefore 
possibly inducing a different utilization efficiency. The pheno-
typic divergence observed in PM experiments between BC12 
and BC5 in the presence of salicin and amygdalin, and in the 
presence of the product of the first amygdalin cleavage, i.e. 
gentiobiose, can be due to possible differences in the speci-
ficity of PTS EII transporters and beta- glucosidase systems as 
previously reported [27].
The carboxylic acids' utilization profile was similar in the 
two strains (Fig. 1a), although BC5 showed higher meta-
bolic activity on lactic acid and pyruvic acid. These findings, 
together with the higher respiration rate on glucose, indicate 
that BC5 strain has an improved homolactic fermentation 
efficiency as compared to BC12. Despite the low number 
of alcohols and C- source amino acids that were generally 
metabolized by the two strains, BC5 also showed a higher 
metabolic performance with these compounds (Fig. 1a, c). 
BC5 and BC12 strains were also distinct in the capacity to 
utilize the amines, fatty acids and polymers. In particular, 
only BC5 could metabolize amines (i.e. phenylethylamine 
and sec- butylamine) and only BC12 could metabolize 
fatty acids (i.e. Tween 20, 40 and 80). While the first two 
compounds can be associated to amine oxidase activity 
[28–30], the three fatty acids utilized by BC12 are deriva-
tives of poly- oxyethylenesorbitan and can be used by some 
Lactobacillus strains as a source of unsaturated fatty acids 
[31]. Regarding the polymers tested in PM, both the strains 
could utilize dextrin and pectin, although BC12 showed 
higher metabolic activities on these substrates. Further-
more, only BC12 is able to utilize cyclodextrins and gelatin 
and only BC5 can metabolize inulin and mannan (Fig. 1a).
nitrogen sources
BC5 and BC12 strains could metabolize 13 and 14 nitrogen 
sources, respectively, out of the 95 compounds belonging to 
this PM category assay. They shared the capacity to utilize six 
of them, i.e. four amino acids, one amino sugar and alloxan 
(Fig. 1b). On the other hand, more than half of the nitrogen 
sources utilized were strain- specific (indicated with * or $ 
in Fig. 1b, c). From a genotypic point of view, the capacity 
of L. crispatus BC5 to utilize arginine could be related to 
the presence of the arcA gene in its genome encoding an 
arginine deiminase, which is able to convert arginine into 
citrulline and NH3 (Fig. 2). However, BC5 did not possess 
the additional genes involved in the subsequent conversion 
of citrulline into ornithine [ornithine trans- carbamoylase 
(encoded by arcB), carbamate kinase (encoded by arcC), 
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Fig. 1. Carbon and nitrogen sources metabolized by L. crispatus BC5 and L. gasseri BC12. Heatmaps represent metabolic activities of BC5 
and BC12 in the presence of carbon sources (a) and nitrogen sources (b). (c) Correlation between the metabolic activities of L. crispatus 
BC5 and L. gasseri BC12 assessed in the presence of the carbon and nitrogen sources tested in PM assay. The metabolic activities of 
BC5 and BC12 are represented as dots on a 2D scatterplot. Plot bands represent mean (μA) and standard deviation (σA) from the mean 
of the activity difference (ΔA). The points located outside of the standard deviation band represent compounds inducing significantly 
different metabolic responses in BC5 and BC12. In particular, dots below and above the bands represent PM compounds inducing higher 
metabolic activity in BC5 compared to BC12 and higher metabolic activity in BC12 compared to BC5, respectively. Numbers in the plot 
represent the PM chemicals listed in (a). In (a) and (b), * indicates carbon and nitrogen sources metabolized only by BC5, $ indicates 
carbon and nitrogen source metabolized only by BC12.
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Table 2. Genetic features of L. crispatus BC5 and L. gasseri BC12 involved in differentially metabolized carbon and nitrogen sources
Metabolism§ KO† LC BC5 hits‡ (no.) LG BC12 hits‡ 
(no.)
KO name
Galactose6/ Lactose8/Tagatose$ K00849 1 1 galK; galactokinase
K00850 1 1 pfkA; 6- phosphofructokinase
K00965 3 2 galT; UDPglucose- hexose-1- phosphate 
uridylyltransferase
K01182 1 3 malL; oligo-1,6- glucosidase (non- direttamente 
coinvolta in metab galattosio)
K01190 3 0 lacZ; beta- galactosidase
K01220 0 3 lacG; 6- phospho- beta- galactosidase
K01635 0 1 lacD; tagatose 1,6- diphosphate aldolase
K01784 1 1 galE; UDP- glucose 4- epimerase (questa non- 
coinvolta in met galattosio)
K01785 2 2 galM; aldose 1- epimerase
K01819 0 2 lacA;lacB; galactose-6- phosphate isomerase
K01835 1 1 pgm; phosphoglucomutase
K02786 0 3 lacF; lactose PTS system EIIA
K02788 0 3 lacE; lactose PTS system EIICB
K20112 1 2 gatA; galactose PTS system EIIA
K20113 0 1 PTS- Gal- EIIB (gatB); galactose- specific IIB
K20114 0 1 PTS- Gal- EIIC (gatC); galactose- specific IIC
K16209 1 0 lacS, galP, rafP; lactose/raffinose/galactose permease
Maltose5 K02777 2 1 crr; sugar PTS system EIIA component
K02750 2 0 glvC; alpha- glucoside PTS system EIICB
K01232 1 0 glvA; maltose-6'-phosphate glucosidase
Sucrose20 K02810 2 1 scrA; sucrose PTS system EIIBCA or EIIBC
K01193 3 1 sacA; beta- fructofuranosidase
K00847 1 1 scrK; fructokinase
K01810 1 1 pgi; glucose-6- phosphate isomerase
K01835 1 1 pgm; phosphoglucomutase
K00692 1 0 sacB; levansucrase
K00690 2 1 sucP; sucrose phosphorylase
N- acetyl- galactosamine$ K02744 0 2 agaF; N- acetylgalactosamine PTS system EIIA
K02745 0 1 agaV; N- acetylgalactosamine PTS system EIIB
Fructose15 K02770 1 2 fruA; fructose PTS system EIIBC or EIIC
K00882 1 3 fruK; 1- phosphofructokinase
K01624 1 1 fbaA; fructose- bisphosphate aldolase
K01803 1 2 tpiA; triosephosphate isomerase (TIM)
Continued
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Metabolism§ KO† LC BC5 hits‡ (no.) LG BC12 hits‡ 
(no.)
KO name
Melibiose*/ Maltotriose17 K10117 1 0 msmE; raffinose/stachyose/melibiose transport 
system substrate- binding protein
K10118 1 0 msmF; raffinose/stachyose/melibiose transport 
system permease protein
K10119 1 0 msmG; raffinose/stachyose/melibiose transport 
system permease protein
K10112 4 2 msmX, msmK, malK, sugC, ggtA, msiK; multiple 
sugar transport system ATP- binding protein
K07407 1 1 galA, rafA; alpha- galactosidase
Trehalose24 K02777 2 1 crr; sugar PTS system EIIA component
K01232 1 0 glvA; maltose-6'-phosphate glucosidase
K01226 0 1 treC; trehalose-6- phosphate hydrolase
Arginine* K01478 1 0 arcA; arginine deiminase
Dipeptides/ Oligopeptides K03305 1 0 di-/tripeptide transporter
K15580 7 0 oppA, mppA; oligopeptide transport system 
substrate- binding protein
K15581 1 0 oppB; oligopeptide transport system permease 
protein
K15582 1 0 oppC; oligopeptide transport system permease 
protein
K15583 1 0 oppD; oligopeptide transport system ATP- binding 
protein
K10823 1 0 oppF; oligopeptide transport system ATP- binding 
protein
§ Subscripts correspond to those reported in Fig. 1. Furthermore, * and $ indicate carbon and nitrogen sources metabolized in PM assay by 
either L. crispatus BC5 or L. gasseri BC12, respectively.
†GenBank locus tags associated to KO can be retrieved from Tables S1 and S2.
‡Number of genes assigned to the same functional orthologue group (from data in Tables S1 and S2).
Table 2. Continued
membrane transport protein (encoded by arcD)] [32, 33], 
which explains the inability of BC5 also to utilize arginine 
as a carbon source. Furthermore, differently from BC12, 
BC5 could utilize di- peptides and alpha- amino fatty acids 
as nitrogen sources. The different nitrogen sources' utiliza-
tion capability of BC5 and BC12 might be associated to the 
presence in each strain of a different dipeptides/oligopep-
tides' uptake system, i.e. the Opp system in BC5 and the 
DtpT in BC12 (Table 2), which might be involved in the 
intake of a specific range of oligopeptides due to affinity 
issues [34]. Regarding the nitrogen sources utilized only by 
BC12, no specific genetic determinants could be detected 
based on the genome functional annotation.
osmotic and ionic stressors
The pH range at which L. crispatus BC5 and L. gasseri BC12 
were metabolically active was similar (i.e. pH 4–8.5); further-
more, these two strains were equally resistant to several osmo-
lytic stressors (i.e. NaCl, sodium sulphate, ethylene glycol, 
sodium phosphate, sodium nitrate and sodium nitrite). On the 
other hand, the osmotic stress induced by potassium chloride, 
sodium lactate and sodium benzoate differently affected the 
two strains. Indeed L. gasseri BC12 was metabolically active at 
higher concentrations of these three stressors as compared to 
L. crispatus BC5. Furthermore, L. gasseri tolerated urea up to 
4 %, while the minimum concentration tested (2 % urea) was 
enough to completely inhibit the metabolic activity of BC5 
(Fig. 3). The presence of glycerol and trehalose sustained the 
growth of both BC5 and BC12 in the presence of high osmo-
larity (NaCl 6 %), while the ability to utilize betaine, proline 
and trigonelline as osmoprotectants distinguished the two 
strains (i.e. betaine and proline by BC12 and trigonelline by 
BC5) (Fig. 3).
Some genetic traits could be associated with the overall 
improved resistance and/or tolerance capacities of BC12 
strain as compared to BC5 towards osmotic stressors. 
For instance, the presence of two copies of the potassium 
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Fig. 2. Metabolic pathways of carbon and nitrogen sources differentiating BC5 and BC12 based on phenotype microarray (PM) and 
genome functional annotation. Metabolic reactions are indicated with coloured arrows: green for BC5- specific reactions, red for BC12- 
specific reactions, dark grey for reactions predicted to occur in both these strains. Most of the functions displayed are included in the 
core genome of each species with a few exceptions (indicated with #). The gene products are indicated in Table 2 except for DAK that 
stands for dihydroxyacetone kinase. Carbon and nitrogen sources are indicated within orange boxes with the same subscripts of Fig. 1 
and Table 2. The box with ND indicates the absence of a specific gene predicted to encode that function by genome annotation.
uptake permease (KUP) gene in the BC12 genome might 
relate to the capacity of this strain to stand higher 
concentrations of KCl (Table 3). These genes encode a low 
affinity K+ uptake system KUP possibly involved in the 
initial phase of osmo- adaptation [35]. Regarding the utili-
zation of compatible solutes as osmoprotectants, genes 
encoding all the components of an osmoprotectant trans-
port system (Opu) were detected in BC12 genome but not 
in BC5 (Table 3). This genetic trait can be associated with 
L. gasseri strain’s exclusive capacity to utilize the osmotic 
protectants l- proline and betaine. On the other hand, 
choline could not be used by BC12 to counteract osmotic 
stress, which might be due to a possible lower affinity 
of the Opu system toward this compound [36]. Genes 
encoding glycerol ABC transporters (GRH99_01765, 
GRH99_04495, GRH99_08730, GRI01_08425) and treha-
lose specific IIB and IIC components were detected in 
the two genomes under analysis; these genes are possibly 
involved in the cell import of glycerol and trehalose as 
osmoprotectants to sustain the growth of the two strains 
in the presence of the highest NaCl concentration tested, 
i.e. 6 % [37, 38].
Tolerance/resistance to chemical stressors including 
antibiotics and metals
Among the drugs and chemicals tested, BC12 was metaboli-
cally active in 86 chemicals/drugs, while L. crispatus BC5 
showed resistance to 48 stressors (Fig.  4). In particular, 
both strains were resistant to 12 antibiotics out of the 91 
antibiotics tested (Fig. 4) and both the strains were sensi-
tive to aminocoumarin, lincomycin, nitrofurans, rifamycin 
and sulfonamides antibiotic classes. As compared to BC5, 
BC12 strain showed resistance to additional 20 antibiotics 
belonging to aminoglycosides, β-lactams, cephalosporines, 
fluoroquinolones, glycopeptides, macrolides, nitroimida-
zole and quinolones classes (Fig. 4). At the genetic level, 
the higher metabolic activity of BC12 in the presence of 
macrolides could be associated to the presence in its genome 
of genes encoding both a macrolide ABC transporter (macB, 
GRI01_09250) and a permease (macA, GRI01_09255) 
(Table 3). BC12 was also found to be slightly more resistant 
than BC5 to some β-lactams (Fig. 4). This property could 
be correlated to the presence in BC12 genome of a higher 
number of different genes encoding β-lactamases of class 
A and C (three and four in BC12, one and two in BC5, 
respectively) and an ABC efflux transporter AbcA, which 
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Fig. 3. Osmotic and ionic stress resistance/tolerance in L. crispatus BC5 and L. gasseri BC12. Heatmaps represent metabolic activities of 
BC5 and BC12 within a metabolic value range of 0 (red) – 50000 (green).
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Table 3. Genetic features of L. crispatus BC5 and L. gasseri BC12 involved in stress response





Osmotic K05845 0 1 opuC; osmoprotectant transport system 
substrate- binding protein
K05846 0 1 opuBD; osmoprotectant transport system 
permease protein
K05847 0 1 opuA; osmoprotectant transport system 
ATP- binding protein
K03549 1 2 KUP; system potassium uptake protein
K03455/K03315 2 3 Monovalent cation / H(+) antiporter
Beta- lactam/ quinolones K18104 0 1 abcA; multidrug resistance, efflux pump 
AbcA
Beta- lactams – 4 7 beta- lactamase/penicillin binding proteins‡
Macrolide K19350 2 1 lincosamide and streptogramin A transport 
system ATP- binding/permease protein
K05685 0 1 macB, macrolide transport system ATP- 
binding/permease protein
Aminoglycosides K00662 1 1 aacC; Aminoglycoside 3- N- 
acetyltransferase
K19272 0 1 aph; aminoglycoside 3’-phosphotransferase
Fluoroquinolones K18908 2 0 mepA; multidrug resistance, efflux pump 
MepA
Tetracyclin K18220 1 1 Ribosome protection- type tetracycline 
resistance related proteins
Arsenic K03892 1 0 arsR; ArsR family transcriptional regulator
K00537 1 0 arsC; arsenate reductase
K03325 1 0 arsB; arsenite transporter
Copper – 1 1 copY; negative regulator of copper 
transport operon
K17686 3 3 copA; P- type Cu+transporter
K07213 1 0 copZ; copper chaperon
K01533 1 1 copB; P- type Cu2+transporter
Cobalt, zinc and cadmium K16264 1 1 czcD; cobalt- zinc- cadmium efflux system
– 0 1 czrA; ArsR family transcriptional regulator, 
zinc- responsive transcriptional repressor
Bile resistance K01442 1 2 Choloylglycine hydrolase/bile salt 
hydrolase [EC:3.5.1.24]
– 2 0 Putative Bile Salt Transporter§,||
Continued
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Others K04078 1 1 chaperonin GroES
K03687 1 1 molecular chaperone GrpE
K04043 1 1 molecular chaperone DnaK
K03686 1 1 molecular chaperone DnaJ
K04077 1 1 chaperonin GroEL
K04083 1 1 molecular chaperone Hsp33
K01358 1 1 ATP- dependent Clp protease, protease 
subunit
K03544 1 1 ATP- dependent Clp protease ATP- binding 
subunit ClpX
K06149 2 1 universal stress protein A
K11065 1 1 thioredoxin- dependent peroxiredoxin
K08161 2 1 MFS transporter, DHA1 family, multidrug 
resistance protein
K18926 2 4 MFS transporter, DHA2 family, lincomycin 
resistance protein
K18936 1 1 MFS transporter, DHA2 family, multidrug 
resistance protein
K00383 0 1 Glutaredoxin reductase
*Phenotypic data obtained for each stressors category and/or specific stressors are reported in Figs 3 and 4, except for ‘bile resistance’ and 
‘others’.
†GenBank locus tags associated to KO can be retrieved from Tables S1 and S2.
‡Predicted via manual curation. Ref L. crispatus BC5: GRH99_00740, 07030, 08995, 06145; Ref L. gasseri BC12: GRI01_00605, 06430, 05880, 
07430, 08775, 05675, 05870.
§Predicted via manual curation: GRI01_06085.
||Predicted as pseudogene by NCBI annotation pipeline and therefore not included in pan- genome analysis.
Table 3. Continued
are involved in the beta- lactams degradation and extrusion, 
respectively. Additionally, on the basis of previous findings, 
AbcA transporter can be associated with BC12 resistance 
towards polymyxin B [39] and the quinolone pipemidic acid. 
L. gasseri BC12 also showed higher resistance than BC5 to 
fluoroquinolones, except for ciprofloxacin, towards which 
both the strains showed the same tolerance. In addition to 
possible non- specific multidrug efflux pumps that might be 
involved in these antibiotics resistance, we detected in BC12 
genome an ABC transporter (GRI01_02970) showing 53 % 
similarity with the multidrug efflux ABC transporter LmrA 
that is responsible for the quinolones efflux in Lactococcus 
lactis [40]. Regarding the genetic determinants associated 
with antibiotic resistance in L. crispatus BC5, this strain 
possessed two mepA genes encoding MATE family multi-
drug efflux pumps possibly involved in the resistance to 
ciprofloxacin, gentamicin, streptomycin and kanamycin. 
With regard to the resistance to the three aminoglyco-
sides shown in Fig. 4, both the strains carried the genes 
aaaC3 encoding the aminoglycoside N3'-acetyltransferase 
(GRH99_07855) involved in gentamycin resistance 
mainly. At the same time, only BC12 possessed the aph 
gene encoding the aminoglycoside 3′-phosphotransferase 
(GRI01_08780), which phosphorylates the kanamycin 
through an ATP- dependent mechanism. Both these genes 
were previously associated with aminoglycoside resistance 
in other Lactobacillus spp. [41].
PM experiments testing the resistance/tolerance to 26 
metals and metalloids showed that BC12 and BC5 strains 
were both metabolically active in the presence of four 
metals, although BC12 generally showed higher metabolic 
activity values. Further, the L. gasseri strain was resistant to 
other three metals indicated with $ in Fig. 4. From a genetic 
point of view, copper resistance could be associated with the 
presence of the operon copYACB in the genomes of both 
strains (Table 3). CopY acts as a negative regulator of the 
cop genes' expression while copA and copC encode soluble 
periplasmic Cu+- binding proteins, which assist CopB in 
copper extrusion. copB encodes a copper- translocating 
P- type ATPase that shows similarity with lead, cadmium, 
zinc and mercury transporting ATPase, therefore being 
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Fig. 4. Drug and chemical resistance of L. crispatus BC5 and L. gasseri BC12. Heatmaps represent metabolic activities of BC5 and BC12 
in the presence of four different concentrations (from 1 to 4) of drugs and toxic chemicals. Only chemical compounds that allowed 
metabolic activity detection in at least one strain are reported. $ indicates the chemicals and drugs towards which only BC12 showed 
resistance/tolerance
probably involved in other metal resistance phenotypes. 
Interestingly, in BC5 genome, one of the two cop operons 
(GRH99_09225–09235) is located within a 13 Kbp- long 
genomic island, including the gene encoding the MDR 
efflux pump of the MATE family. A czcD gene encoding a 
cation transporter involved in multi- metal (cobalt, zinc and 
cadmium) resistance was detected in both BC5 and BC12 
genomes. However, only in BC12 this gene was flanked by a 
czrA gene encoding the metal regulator ArsR/SmtB, which 
might contribute to an efficient metal- stress response [42]. 
This might explain the resistance to cobalt and the higher 
resistance to zinc shown by BC12 compared to BC5. On 
the other hand, the higher susceptibility to arsenite and 
antimonites shown by BC5 could not be explained at the 
genetic level as BC5 but not the BC12 genome carries ars 
genes (i.e. arsRBC operon), which are the genetic traits 
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typically associated to the bacterial resistance to arsenic 
and antimony [43]. Possible additional cationic antiporter 
might be involved in arsenite resistance, although further 
analyses are needed.
Multidrug efflux proteins, possible multidrug ABC trans-
porters, as well as proteins involved in oxidative stress 
response and other detoxification processes (Tables  3, 
S1 and S2) can support the ability of the two strains to 
resist some of the toxic molecules included within the 119 
stressors classified as miscellaneous. In this regard, BC12 
and BC5 shared the resistance to 16 of these stressors; 
further, the L. gasseri strain showed tolerance to an addi-
tional 31 compounds (Fig. 4). From a genotypic point of 
view, both strains possess a thiol peroxidase, Tpx- type 
(EC 1.11.1.15), that might be involved in oxidative stress 
resistance. However, only the L. gasseri strain also possesses 
a glutathione reductase that might be involved in protec-
tion mechanisms from different physiological stressors, 
including toxic concentrations of metal ions, and osmotic 
and acid stresses [44]. Lastly, in both strains, a bile- salt 
hydrolase gene was found, which is related to still unclear 
tolerance mechanisms to these detergent- like biological 
molecules and possibly to other toxicants (e.g. detergent 
and antibiotic) that were tested in PM assay (Table 3). In 
BC12, two tandem genes encoding putative bile trans-
porter genes (one partial and one complete) are organized 
in operon together with one of the two bile- salt hydrolase 
gene typical of lactobacilli strains isolated from the human 
environment [45].
Species-wide analysis of the genetic traits 
associated with the phenotypic differences 
between L. crispatus BC5 and L. gasseri BC12
A strain- level pan- genome analysis was performed to deter-
mine whether BC5 and BC12 key genes supporting the 
phenotype- genotype association were conserved in the core 
genome of the corresponding species. The pan- genome of 
the L. crispatus species was represented by 5609 clusters of 
homologue proteins, being 1334 shared across 90 % of the 
strains (soft- core genome) and 38 only present in BC5 (Fig. 
S1). As compared to L. crispatus, the L. gasseri pan- genome 
included a lower number of clusters (i.e. 3268) with a soft- core 
genome of 1259 clusters and 34 BC12 singletons (Fig. S2).
Overall, most of the strain- specific features included in clus-
ters of each soft- core genome, were linked to the metabolism 
of sucrose, N- acetyl- galactosamine, galactose, and lactose, 
maltose, fructose, melbiose, maltotriose, trehalose and 
d- tagatose (Figs 5 and 6, Tables S9 and S10). The exceptions 
are the sucrose phosphorylase genes that are present in both 
BC5 and BC12 but not in the soft- core of their respective 
species, and the levansucrase/invertase gene that was found in 
BC5 and only in a few members of L. crispatus species (Figs 5 
and 6, Tables S9 and S10).
With regard to nitrogen metabolism, the BC5 arginine 
deiminase was identified in approximately 80 % of the of 
L. crispatus strains, while most of the BC5 genes encoding 
di- and oligo- peptide transport systems were included in clus-
ters within the L. crispatus soft- core genome (Fig. 5, Table S9).
Genes of L. crispatus BC5 and L. gasseri BC12 that were 
functionally linked to osmotic stress tolerance, heavy metals 
and resistance to antibiotics were generally conserved among 
members belonging to the corresponding species (Figs 5 and 
6, Tables S9 and S10). Among the genetic features associated 
to stressors resistance, only the BC5 ars operon (arsRBC) 
occurred in a few L. crispatus strains, therefore not being 
included in the L. crispatus core genome (Fig. 5, Table S9).
Finally, we investigated whether key genes linked to the 
phenotypic differences between BC5 and BC12 were 
significantly correlated with the vaginal source. Within the 
L. crispatus pan- genome, we found 439 gene clusters to be 
more represented in strains isolated from the vaginal niche 
(Fig. S1, Table S3), among these, 66 gene clusters were also 
detected in BC5 (Fig. S1). Despite most of them were not 
assigned to KO groups, BC5 gene clusters associated with 
the vaginal origin were linked to amino acid metabolism 
and transport (e.g. arginine deiminase, Opp oligopeptide 
transport system), nutrient importer, pH stress tolerance, 
cofactor biosynthesis, defence system, environmental sensing 
(Table S11). In contrast, no gene clusters in the L. gasseri pan- 
genome were significantly correlated with the vaginal source 
(Table S4).
DISCuSSIon
Persistence and colonization of Lactobacillus spp. in the 
human vaginal tract are dependent on a series of factors 
associated with the presence of other micro- organisms, the 
interactions with the host, the local nutrient availability and 
stress conditions. In this context, several studies have analysed 
possible mechanisms involved in vaginal niche adaptation, 
fitness and maintenance of Lactobacillus spp. mainly on the 
basis of comparative genomic studies correlating genomic 
features with the isolation niche [13, 46]. Conversely, only few 
data are available about the effect of different nutrients and 
stress conditions on the metabolic activity of Lactobacillus 
spp. strains. In this work, we investigated, using the high- 
throughput and standardized phenotype microarray assay, 
the metabolic response of the two strains L. crispatus BC5 and 
L. gasseri BC12 in the presence of a wide range of nutritional 
and stress factors; since some of these factors characterize 
also the vaginal niche, they may influence the relationship 
of symbiosis between the vaginal microbiota and the host. 
In particular, BC5 showed a higher capacity to utilize carbon 
sources (in terms of a number of metabolized compounds 
and metabolic activity values), while BC12 showed a general 
higher capacity to resist/tolerate stressors. This is in line with 
the results obtained from API test reported in a previous study 
that pointed out the capacity of L. crispatus strains to ferment a 
higher number of sugars as compared to L. gasseri strains [47]. 
Furthermore, the phenotypic diversity that we detected with 
PM assay was partially supported by differences at genetic/
genomic level and related to the import and/or metabolism of 
nutrients or to the export and/or detoxification of stressors. 
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Fig. 5. Occurrence of L. crispatus BC5 genetic traits in L. crispatus pan- genome. Only genetic traits associated with the phenotypic 
differences between BC5 and BC12 in carbon metabolism (a) and stressors (b) are shown (these genetic traits correspond to those 
shown in Table 2). Lactobacillus strains isolated from the vaginal niche are shown in pink. Species- level conservation (in percentage) of 
each genetic trait is reported on the left of the heatmaps (as barplot). Columns are annotated according to the isolation source of the 
strains while rows are ordered according to the metabolic categories (indicated in the legends).
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Fig. 6. Occurrence of L. gasseri BC12 genetic traits in L. gasseri pan- genome. Only genetic traits associated with the phenotypic differences 
between BC12 and BC5 in carbon metabolism (a) and stressors (b) are shown (these genetic traits correspond to those shown in Table 3). 
Lactobacillus strains isolated from the vaginal niche are shown in pink. Species- level conservation (in percentage) of each genetic trait is 
reported on the left of the heatmaps (as barplot). Columns are annotated according to the isolation source of the strains while rows are 
ordered according to the metabolic categories (indicated in the legends).
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Most of these specific BC5 and/or BC12 genetic traits were 
also found in each species’s core genome giving indications 
on the conservation of specific phenotype- associated genes 
among all the L. crispatus and L. gasseri strains. Among these, 
some of the genes of L. crispatus BC5 that are mainly associ-
ated with amino acid and carbohydrate metabolism/trans-
port and pH stress tolerance were found to be significantly 
correlated with the vaginal source. Comparative genome 
analyses have been previously focused on the identification 
of habitat- specific traits in the vaginal lactobacilli genomes 
[48]. In line with our results, previous studies on some 
L. crispatus strains reported a correlation between genotypic/
phenotypic features and isolation sources concerning both 
nutrient utilization and acid resistance [46, 47]. These authors 
also found some phenotypic features associated with possible 
niche- specific adaptation in L. gasseri strains (vaginal against 
intestinal) [47]. However, in our work, we have not detected 
specific genes in L. gasseri pan- genome that were significantly 
correlated with the vaginal isolation source, probably because 
of the limited number of genomes available for this species.
L. crispatus BC5 and L. gasseri BC12 metabolic 
activities and genetic traits associated with the 
vaginal colonization/persistance
One of the most important aspects of microbial colonization 
of any environmental niche is utilizing the available nutrients 
for growth [49]. Within the context of vaginal niche, the nutri-
ents typically present are free mono- and oligosaccharides, 
glucosamine, glycoproteins, glycerol, lactic acid, acetic acid, 
albumin, mucin, urea and ions (e.g. Na+, K+ and Cl-) [50–52]. 
In particular, glycogen and glucose represent the major 
carbohydrates of the vaginal fluid, while mannose, maltose 
and glucosamine were found in much smaller quantities 
[53]. PM results indicated that BC5 strain could metabolize 
glucose, pyruvic acid and lactic acid at a higher rate indicating 
a higher lactic acid fermentation efficiency, compared to 
BC12. BC5 also showed higher metabolic activity in the pres-
ence of mannose [54], while the two strains equally utilized 
acetic acid and glucosamine. None of the two strains could 
directly utilize glycogen; however, BC5 showed higher meta-
bolic activity in the presence of the glycogen debranching 
products (i.e. maltose, maltotriose and glucose), which can 
be released in the vaginal tract through depolymerization 
activity of amylases from the host or other bacterial strains 
[50, 55]. The previous study indicated that glycogen could be 
utilized as carbon and energy source by L. crispatus strains. 
This metabolic feature was associated with the expression of 
an active pullulanase type I with an N- terminal signal peptide 
probably involved in extracellular localization of the enzyme 
to degrade extracellular glycogen correctly [56]. Therefore, 
the inability of BC5 to utilize glycogen in PM might be due to 
amino acid deletion present in the N- terminal sequence of its 
pullulanase gene (data not shown). On the other hand, some 
genes encoding transporters and enzymes involved in the 
glycogen debranching products' consumption were identified 
in BC5 and were included in L. crispatus core genome, while 
they were not found in the L. gasseri core genome, including 
BC12 (Table 2). In particular, in the case of maltose, a maltose 
6- phosphate glucosidase activity can support the capacity of 
only BC5 to utilize maltose. This gene is included in an operon 
that was previously identified in all the 67 L. crispatus human 
strains under analysis and was predicted to be associated with 
the import and metabolism of trehalose [46].
Both of the strains could utilize the mucin- derived compound 
N- acetyl- glucosamine as both nitrogen and carbon source, 
while only BC12 could metabolize N- acetyl- galactosamine. 
These compounds might arise from mucin oligosaccharide 
degradation by both beneficial bacteria and pathogens, being 
mainly studied in the gastrointestinal tract [57, 58]. Unlike 
BC12, BC5 strain showed the capacity to utilize amines and 
amides as carbon sources. These properties might be associ-
ated with synergistic relationships that may occur within the 
vaginal microbiota, even under bacterial vaginosis condition 
in which a series of biogenic amines are produced by patho-
genic bacteria [59–61].
Only a few amino acids were metabolized by BC5 and BC12 
as carbon source, whereas a higher number of them could 
be utilized as nitrogen sources. Within the host, nitrogen 
is primarily available as free amino acids and proteins [62]. 
Among the amino acids that are normally present in the 
vaginal tract, aspartic acid and tryptophan could be utilized 
by both the strains [63], while only BC12 could metabolize 
glutamic acid as both carbon and nitrogen source and argi-
nine was utilized as nitrogen source only by BC5. This latter 
capacity was associated with the presence in the BC5 genome 
of a gene encoding an arginine deiminase that converts argi-
nine into citrulline and NH3, also contributing to counteract 
environmental stresses, such as acidity and starvation [32, 64]. 
BC5 could also utilize di- peptides as nitrogen and carbon 
sources in association to the presence of a specific peptide 
transport system that might be involved in these molecules' 
import. Interestingly, these genes were present in the 
L. crispatus core genome and significantly correlated with the 
vaginal origin of these species strains, possibly corresponding 
to a metabolic advantage for vaginal niche adaptation. The 
ability to efficiently assimilate complex nitrogen molecules 
was also described in a food- related L. plantarum strain. In 
particular, dipeptides efficiently sustained the growth of this 
strain under nutritional stress conditions [65].
Among those carbon sources that could not be utilized by 
none of the two strains but are important in the vaginal tract, 
it is noteworthy to mention glycerol. Glycerol did not seem to 
be utilized by any of the two strains in spite of the presence 
in their genomes of genes encoding a glycerol-3- phosphate 
dehydrogenase, a glycerol kinase and a glycerol facilitator 
protein. On the other hand, glycerol could be used as osmo-
protectant by both BC5 and BC12. Glycerol is usually present 
at low concentration in the vaginal niche [50], however, it has 
been described as an underappreciated carbon source due to 
upregulation of glycerol pathways in L. iners under bacterial 
vaginosis conditions [66]. Furthermore, both the Lactoba-
cillus strains could not use urea as carbon and/or nitrogen 
source and this is in line with the lack of a urease coding 
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operon in their genomes. However, BC12 showed resistance 
to urea when added as osmolyte stressor up to 4%, probably 
due to non- specific resistance mechanisms.
The capacity to resist/tolerate chemical stressors is also an 
important aspect for the colonization and persistence of a 
bacterial population within a specific environmental niche. 
In particular, during their life as mutualistic organisms in the 
vaginal niche, lactobacilli are expected to encounter stresses 
related to antibiotics treatments and detergents. Antibiotics 
greatly influence the human microbiota and the microbial 
composition of the vaginal niche is known to undergo rapid 
modification during and after antibiotic treatments [67–69]. 
The evaluation of the survival capacity of autochthonous 
strains during antibiotic treatment may allow to predict their 
persistence in the vaginal niche and their metabolic advan-
tage during specific antibiotic therapy [41]. A recent work 
about the antibiotic susceptibility of 182 Lactobacillus strains 
(including one type strain for each L. gasseri and L. crispatus 
species) reported that resistance to trimethoprim, vanco-
mycin and kanamycin were common phenotypes within this 
genus. In this regard, in our work we found that only BC12 
was resistant to trimethoprim and only when added at the 
lowest concentration, while both BC5 and BC12 strains were 
equally resistant to vancomycin and kanamycin. Generally, 
Lactobacillus spp. strains were found to be susceptible to low 
concentrations of β-lactams [69]. The apparent contrasting 
results on the resistance of BC5 and BC12 towards some 
β-lactams (including ampicillin and penicillin) might be due 
to the concentrations tested in the PM assay that are typically 
active towards Gram- negative bacteria and probably much 
lower than the MICs previously described [3]. From a genetic 
point of view, β-lactamase encoding genes were identified 
in both the strains and no mutations of the genes encoding 
penicillin- binding proteins (PBPs) were detected that could 
sustain a strong resistance phenotype [70]. Additional multi-
drug transport systems and oxidative stress response compo-
nents might be involved in non- specific and multifactorial 
detoxification mechanisms of antibiotics and detergents [71]. 
In this regard, previous studies reported that deletion of one 
of the five transporters [generally annotated as a multidrug 
resistance (MDR) protein] rendered the mutant strains of 
L. acidophilus NCFM more sensitive to detergent- like mole-
cules (i.e. bile) and some antibiotics [45, 72]. Furthermore, the 
induction of general stress response, the protection against 
oxidative damages, as well as the global glycolytic reorganiza-
tions were described to be involved in Lactobacillus resistance 
mechanisms to detergent- like molecules [45].
Besides antibiotics and detergents, the research interest in 
the resistance/tolerance of vaginal Lactobacillus spp. strains 
to osmolytes and other toxic compounds such as metal(loid)
s, can be associated to their possible therapeutical application 
as probiotics [64, 65, 73, 74]. In the PM assay, both BC12 
and BC5 strains showed the capacity to resist/tolerate some 
of these toxic compounds and chemical stressors, despite 
the general higher performance of the L. gasseri strain. In 
this regard, BC12 showed higher tolerance towards salts and 
molecules typically present in the vaginal fluid, such as KCl, 
sodium lactate (that is the dissociated form of lactic acid 
existing at neutral pH), and urea. Both the strains showed 
some genetic features associated with the possible accumula-
tion of distinct compatible solutes that were conserved at the 
species- level, while only L. gasseri strains possessed the operon 
encoding the osmoprotectant transport system Opu that 
was previously characterized for its involvement in betaine 
and proline uptake in Lactococcus lactis [75]. In relation to 
metal resistance/tolerance, previous works have reported 
the capacity of Lactobacillus strains to tolerate heavy metals 
such as cadmium and lead [76] by reducing metal toxicity. In 
particular, bioaccumulation and biosorption were described 
to be possible detoxification strategies of Lactobacillus that 
can prevent the exposure of the human tissues to heavy metals 
[77]. The capacity of both BC5 and BC12 strains to resist 
copper, zinc and cadmium can be associated to the presence 
of czc and cop genes, whose molecular mechanisms have 
been extensively studied in model lactic acid bacteria [78]. 
In addition to the presence of specific genes associated 
with detoxification mechanisms that were the focus of 
the present study, specific SNP of the molecular targets or 
other cellular components can contribute to resistance/
tolerance towards different stressors [79]. This aspect can 
influence the strain- level phenotype prediction driven by 
the detection of stress- related genetic traits in the species 
core genome or even in the strain genome. For instance, 
the presence of SNP in crucial cell- response components 
might justify the presence of specific resistance/tolerance 
in Lactobacillus spp. strains that did not show to possess 
the expected genetic determinants in their genomes [80]. 
Additionally, defective expression of the resistance genes 
can hamper the correlation between the resistance pheno-
type and genotype. This might explain the inability of BC5 
to resist arsenic despite the presence of ars genes in its 
genome.
In conclusion, the results of our study provide useful indi-
cations on those factors contributing to the predominance 
of BC5 and BC12 strains in a common niche. Although we 
are aware of the restraints of our genetic dataset (which 
excludes uncharacterized genes), the strain- level differ-
ences that are known within Lactobacillus species and the 
limitation of functional assessment only based on genotype 
analysis, we believe that the results from this study can be 
used as the groundwork for further functional analyses 
at the species level also targeting other vaginal bacterial 
strains. Finally, in terms of health- promoting functionality 
that is well known for both BC5 and BC12 strains, our 
findings could provide guidance to be taken into consid-
eration during the development of probiotic formulations 
for enhancing the therapeutic efficacy of these beneficial 
bacteria.
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